《半日总结》恒指跌42点 药明生物挫近6% 汇控绩前靠稳
美股标普500指数及纳指创收市高，港股受个别股份配股拖累，早市走软。恒指低开57点，早段曾跌159点见28,793点，其後曾倒升78点见29,031点，中午前再度回软，半日跌42点或0.1%，报28,910点；国指升5点或0.05%，报10,986点；恒生科技指数升53点或0.6%，报8,538点。大市半日成交额843.58亿元，沪、深港通南下交易半日录得净流入金额分别为3.13亿及8.3亿元人民币。
市场监管总局依法对美团(03690.HK)「二选一」等涉嫌垄断行为立案调查，美团早市股价倒升2.5%报312.6元。阿里巴巴(09988.HK)升1.1%报227元，腾讯(00700.HK)跌1.1%报621.5元，小米(01810.HK)跌0.2%报26.35元，京东(09618.HK)跌0.4%报298元，百度(09888.HK)跌2.2%报209.8元。
其他科网股方面，心动(02400.HK)、美图(01357.HK)及京东健康(06618.HK)各升3.8%至5.3%，恒腾(00136.HK)、阿里健康(00241.HK)、新东方在线(01797.HK)、易鑫(02858.HK)及明源云(00909.HK)各升逾2%。祖龙娱乐(09990.HK)跌3.8%。手机相关股丘钛(01478.HK)及富智康(02038.HK)各升2.1%及2.7%。个人电脑生产商联想集团(00992.HK)跌2.2%。
内需股方面，维他奶(00345.HK)及维达(03331.HK)各升2.2%及2.8%，猫眼娱乐(01896.HK)升5.7%。体育用品股361度(01361.HK)及特步(01368.HK)各升5.6%及7.9%。汽车股长城汽车(02333.HK)升2%。医药股方面，康哲药业(00867.HK)及国药(01099.HK)各升5%及2.5%。
药明生物(02269.HK)遭主要股东折让6.8%配股套现逾115亿元，股价跌5.9%，单股拖累恒指52点。航运股中外运(00598.HK)及中远海控(01919.HK)各升3.7%及3.4%。
黄金股下跌，山东黄金(01787.HK)及中国黄金国际(02099.HK)各跌逾2%。铜价升至逾九年半高，江铜(00358.HK)升2.6%。环保发电股方面，信义光能(00968.HK)跌2.2%。金风科技(02208.HK)首季多赚9%，股价半日跌5.7%。燃气股中燃气(00384.HK)跌4.4%。
其他蓝筹方面，汇控(00005.HK)中午公布季绩，半日升0.3%报45.25元，恒生(00011.HK)则跌0.1%报150.2元。港交所(00388.HK)升0.1%报491.8元，友邦(01299.HK)升0.8%报99.75元，中移动(00941.HK)平收报52.1元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
